Giampiero Favato

About

I began my career in the lifescience industry, in the corporate finance team of Eli Lilly & Co. In 1998 I moved to Schering-Plough as Business Unit Director. When Schering-Plough entered into a joint venture with Merck Sharp & Dohme (MSD) in 2001, I was given a senior leadership role. After two decades of leadership in pharma, I moved into academia in 2006. Since then I published widely in the field of health economics, real options and, more recently, valuation under uncertainty. Essentially, I'm a researcher and a teacher. I am committed to making theoretical research relevant to policy makers and taught material relevant to managers.

My Teaching:

• 2019 - present Financial Management (MBA)
  

• Kingston Business School

• 2012 - present Aspects of Financial Management in Health (ILMH)

• Kingston Business School

• 2010 - present Corporate Finance

• Kingston Business School

• 2006 - 2009 Corporate Finance (MBA)

• Henley Business School

• 2006 - 2007 Managing Financial Resources

• Henley Business School

Academic responsibilities

• Director of Postgraduate Research

Qualifications

• DBA, Henley Management College - Brunel University
• MBA, Booth Graduate School of Business, University of Chicago
• BSc Public Health, Oxford Brookes University

Areas of specialism

• Public health policy
• Health economics
• Inequalities of health
• Impact of uncertainty on equity valuation
• Real Options